Related Experiment Video
Updated: Mar 24, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Implication of protein tyrosine phosphatase SHP-1 in cancer-related signaling pathways
Yadhu Sharma1, Altaf Ahmad2, Samina Bashir1
1Department of Biochemistry, Faculty of Science, Jamia Hamdard, New Delhi-110062, India.
Abstract:
The altered expression of SHP-1 (SH2 domain-containing protein tyrosine phosphatase) as a consequence of promoter hypermethylation or mutations has evidently been linked to cancer development. The notion of being a cancer drug target is conceivable as SHP-1 negatively regulates cell cycle and inflammatory pathways which are an inevitable part of oncogenic transformation. In the present review, we try to critically analyze the role of SHP-1 in cancer progression via regulating the above mentioned pathways with the major emphasis on cell cycle components and JAK/STAT pathway, commencing with the SHP-1 biology in immune cell signaling. Lastly, we have provided the future directions for researchers to encourage SHP-1 as a prognostic marker and curative target for this debilitating disease called as cancer.
Insights
SHP-1 (SH2 domain-containing protein tyrosine phosphatase) alterations are linked to cancer. This review analyzes SHP-1
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- SHP-1 (SH2 domain-containing protein tyrosine phosphatase) expression is altered in cancer via methylation or mutations.
- SHP-1 negatively regulates cell cycle and inflammatory pathways crucial for oncogenesis.
- SHP-1 plays a significant role in immune cell signaling.
Purpose of the Study:
- To critically analyze the role of SHP-1 in cancer progression.
- To investigate SHP-1's regulation of cell cycle and JAK/STAT pathways.
- To explore SHP-1's potential as a prognostic marker and therapeutic target in cancer.
Main Methods:
- Literature review and critical analysis.
- Focus on SHP-1's involvement in cell cycle regulation.
- Emphasis on SHP-1's role in the JAK/STAT signaling pathway.
Main Results:
- Altered SHP-1 expression is associated with cancer development.
- SHP-1 influences key cell cycle components.
- SHP-1 impacts the JAK/STAT pathway, relevant to inflammation and cancer.
Conclusions:
- SHP-1 is a critical regulator of pathways involved in cancer progression.
- SHP-1 presents a promising target for cancer therapy.
- Further research can establish SHP-1 as a prognostic marker for cancer.
Related Concept Videos
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade

